The Centers for Medicare & Medicaid Services today approved for Oklahoma the first state Medicaid plan amendment to allow supplemental rebate agreements involving value-based purchasing arrangements with drug makers. The value-based agreements could produce extra rebates for the state if clinical outcomes are not achieved. “Oklahoma’s plan for value-based drug contracts is an important example of how states can innovate to bring down drug costs,” said Health and Human Services Secretary Alex Azar. In addition, CMS today approved an amendment to Massachusetts’ Section 1115(a) Medicaid demonstration, MassHealth, which permits the state to provide coverage to certain veterans and family members who receive income from state veteran annuities. Massachusetts also proposed a number of flexibilities which CMS did not approve but on which it continues to work with the state, including a request to exclude certain Medicaid-covered outpatient drugs through a closed formulary. In other news, CMS today sent a letter to states clarifying that drugs approved under section 506(c) of the Federal Food, Drug, and Cosmetic Act are covered outpatient drugs and must be covered by states consistent with the Medicaid Drug Rebate Program.

Related News Articles

Headline
The Department of Homeland Security today released a final rule limiting the ability of legal immigrants to adjust or extend their immigration status or gain…
Headline
The Centers for Medicare…
Headline
The House of Representatives today passed and sent to the President a Medicaid-related bill (H.R. 3253) that includes a provision extending the Certified…
Headline
A federal judge yesterday blocked Medicaid work requirements in New Hampshire, as he did earlier this year in Kentucky and Arkansas.
Headline
Medicaid disproportionate share hospital payments to eligible hospitals covered 51% of their uncompensated care costs in 2014, the most recently available…
Headline
The Centers for Medicare…